Connecticut 2025 Regular Session

Connecticut House Bill HB07179

Introduced
3/6/25  
Refer
3/6/25  
Report Pass
3/21/25  
Refer
4/1/25  
Report Pass
4/8/25  
Engrossed
6/4/25  
Report Pass
6/4/25  
Passed
6/4/25  
Chaptered
6/23/25  
Enrolled
6/27/25  

Caption

An Act Concerning Pharmaceutical Marketing And Pharmaceuticals.

Companion Bills

No companion bills found.

Similar Bills

AR HB1301

To Amend The Prior Authorization Transparency Act.

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

AR HB1531

To Prohibit Pharmaceutical Manufacturers From Restricting Or Limiting Prescription Medications To A Limited Distribution Network Of Out-of-state Pharmacies.

FL S0860

Compounded Drugs

DE SJR7

Directing The State Employee Benefits Committee And The Secretary Of Human Resources To Engage With Independent Consultants And Other Supply Chain Tactics For Cost Containment Of Prescription Drugs For State Employees And Retirees Insurance Programs.

CA AB1979

Health care services: artificial intelligence.

CT HB06870

An Act Addressing Patients' Prescription Drug Costs.

CA AB1394

Personal opioid drug deactivation and disposal systems.